CHAPEL HILL, N.C., Jan. 4, 2012 /PRNewswire/ -- Successfully launching a new diabetes product in this digital age still relies heavily on traditional public relations tools, namely press releases, media interviews, health fairs, and educational pamphlets. However, introducing new technologies into a launch plan is an effective way to inform patients and physicians of the new product.

Among the most effective technologies for reaching patients and physicians about a new diabetes product are online advocacy groups, branded web sites, and e-newsletters, according to commercial executives who participated in primary research on "Educating the Marketplace to Support Successful Diabetes Product Launches" conducted by Best Practices, LLC. Podcasts are one of the least effective technologies for informing patients, but achieve some success in reaching physicians.

Download a complimentary white paper at http://www3.best-in-class.com/rr1139.htm that includes selected best practices drawn from extensive primary research with executives from 26 leading companies.

Key insights from other areas of the research include:

• 89% of companies start engaging thought leaders and key investigators in clinical trial protocol development at Phase II or before. The largest response groups signaled Phase II as the kickoff to most thought leader services.
• Engaging thought leaders and key investigators in clinical trial protocol development is rated by 94% of companies as one of the most important thought leader education activities.

"Educating the Marketplace to Support Successful Diabetes Product Launches," a primary research study conducted by Best Practices, LLC, is a 161-page report with more than 450 benchmark metrics and 41 executive narratives, providing launch leaders the most effective physician, payer and patient education practices conducted from clinical development through launch.

Executives and managers in the diabetes therapeutic area use this research to compare their market education tactics and strategies with those of leading organizations.

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC

Back to top

RELATED LINKS
http://www.best-in-class.com